# Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

> **NCT02590692** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Regenerative Patch Technologies, LLC** · enrollment: 16 (actual)

## Conditions studied

- Dry Macular Degeneration
- Geographic Atrophy

## Interventions

- **BIOLOGICAL:** CPCB-RPE1

## Key facts

- **NCT ID:** NCT02590692
- **Lead sponsor:** Regenerative Patch Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-16
- **Primary completion:** 2019-07
- **Final completion:** 2023-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590692, "Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02590692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*